These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34769979)

  • 1. Irritable Bowel Syndrome Prevalence among Participants of Woodstock Rock Festival in Poland Based on Rome IV Criteria Questionnaire.
    Palma J; Antoniewicz J; Borecki K; Tejchman K; Skonieczna-Żydecka K; Maciejewska-Markiewicz D; Ryterska K; Komorniak N; Czerwińska-Rogowska M; Wolska A; Mruk-Mazurkiewicz H; Gudan A; Mazur T; Mijal P; Budawski R; Stachowska Z; Marlicz W; Stachowska E
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis.
    Oka P; Parr H; Barberio B; Black CJ; Savarino EV; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):908-917. PubMed ID: 32702295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
    Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
    Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
    Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ; Yiannakou Y; Houghton LA; Ford AC
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India.
    Goyal O; Nohria S; Dhaliwal AS; Goyal P; Soni RK; Chhina RS; Sood A
    Indian J Gastroenterol; 2021 Apr; 40(2):144-153. PubMed ID: 33226570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    Mishima T; Fukae J; Fujioka S; Inoue K; Tsuboi Y
    J Parkinsons Dis; 2017; 7(2):353-357. PubMed ID: 28157108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of irritable bowel syndrome among Saudi population in Riyadh by use of Rome IV criteria and self-reported dietary restriction.
    Amin HS; Irfan F; Karim SI; Almeshari SM; Aldosari KA; Alzahrani AM; Almogbel AT; Alfouzan SM; Alsaif AA
    Saudi J Gastroenterol; 2021; 27(6):383-390. PubMed ID: 34747875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.
    Chuah KH; Beh KH; Mahamad Rappek NA; Mahadeva S
    J Dig Dis; 2021 Mar; 22(3):159-166. PubMed ID: 33595169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Burden of Illness of Rome IV Irritable Bowel Syndrome in the United States: Results From a Nationwide Cross-Sectional Study.
    Almario CV; Sharabi E; Chey WD; Lauzon M; Higgins CS; Spiegel BMR
    Gastroenterology; 2023 Dec; 165(6):1475-1487. PubMed ID: 37595647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Irritable Bowel Syndrome in Albania.
    Galica AN; Galica R; Dumitrascu DL
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):334-338. PubMed ID: 34551031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
    Goodoory VC; Houghton LA; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14268. PubMed ID: 34532930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria.
    Miwa H
    Patient Prefer Adherence; 2008 Feb; 2():143-7. PubMed ID: 19920955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional bowel disorders in Iranian population using Rome III criteria.
    Sorouri M; Pourhoseingholi MA; Vahedi M; Safaee A; Moghimi-Dehkordi B; Pourhoseingholi A; Habibi M; Zali MR
    Saudi J Gastroenterol; 2010; 16(3):154-60. PubMed ID: 20616409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Study about Knowledge, Attitude, and Practices among Primary Health Care Physicians in Jazan Province, Saudi Arabia, Regarding Rome IV Criteria for Diagnosis of Irritable Bowel Syndrome.
    Abusageah F; Hakami A; Zogel B; Zaalah S; Alfaifi S; Shubayli S; Hakami K; Qadah E; Aldharman S; Hakami F; Alqasemi M; Mobarki M; Alhazmi AH
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.